SEC Form D · filed May 31, 2024
MyMD Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Ian Rhodes · BALTIMORE, MDExecChris Chapman · BALTIMORE, MDExecChristopher Schreiber · BALTIMORE, MDDirectorCraig Eagle · BALTIMORE, MDDirectorMitchell J. Glass · BALTIMORE, MDDirectorBill J. White · BALTIMORE, MDDirectorJude Uzonwanne · BALTIMORE, MDDirectorJoshua Silverman · BALTIMORE, MDDirectorAdam Siegler · NEW YORK, NYDirectorLaurence Kleinman · NEW YORK, NYDirectorMichael Crane · Austin, TXExecQuinn Mcarthur · Dover, DEDirectorMitchell J. Glass · BALTIMORE, MDDirectorJonson Sun · Vancouver, British Columbia, CanadaDirectorBrian Cooper · Austin, TXExecEric Scharaga · Dover, DEDirectorJohn Fichthorn · Norwalk, CTDirectorCharles V. Welden, Iii · Birmingham, ALDirectorKenneth M. Larish · Nashville, TNExecRecof GP · Dallas, TXExecRegan Credit SLP · Dallas, TXDirectorJirka Rysavy · Louisville, CODirectorNed Preston · Louisville, CODirectorJill Cederberg · Fargo, NDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗